World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT00711893
Date of registration: 07/07/2008
Prospective Registration: No
Primary sponsor: Boston Scientific Corporation
Public title: Feature Assessment Study for Indications Based Programming FASt-IBP
Scientific title: Feature Assessment Study for Indications Based Programming
Date of first enrolment: June 2008
Target sample size: 301
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT00711893
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
Austria Belgium China France Germany Greece Latvia Netherlands
Slovakia Spain Switzerland
Contacts
Name:     Konrad Goehl, MD
Address: 
Telephone:
Email:
Affiliation:  Klinikum Nuernberg
Key inclusion & exclusion criteria

Inclusion Criteria:

- indicated for implantation of an ICD or CRT-D device according local hospital implant
criteria guidelines

- Implanted or intended to be implanted with any CE-marked device approved for
implant from the TELIGEN (single or dual chamber ICD) or COGNIS (CRT-D) family
during first implant (no replacements)

- Geographically stable patients who are available for follow-up at a study centre

- Age 18 or above, or of legal age to give informed consent specific to national
law

Exclusion Criteria:

Inability or refusal to sign the Patient Informed Consent

- Pregnant or planning to become pregnant

- Replacement device

- Enrolment in another clinical trial, study or evaluation

- Estimated life expectancy of less than six months per discretion of physician



Age minimum: 18 Years
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Ventricular Fibrillation
Ventricular Flutter
Heart Failure
Ventricular Tachycardia
Intervention(s)
Device: Cognis 100-D, Teligen DR and VR 100 HE
Primary Outcome(s)
Proportion of patients that are programmed by the physician to anything other than the recommended IBP setting [Time Frame: 6 Months]
Secondary Outcome(s)
- Degree of acceptance of IBP - Proportion parameters changed per patient - Differences between recommended and final programmed parameters - Total number of parameter changes from IBP recommendations - Frequency of changes made to a single parameter [Time Frame: 6 Months]
Secondary ID(s)
FASt-IBP 0408
feci 08/1644
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Guidant Corporation
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history